Watching
$Savara (SVRA.US)$ Reuters·
Savara to Present New Data From Pivotal Phase 3 Impala-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap) at the European Respiratory Society (Ers) Congress 2024 September 7th thru 11th
Savara to Present New Data From Pivotal Phase 3 Impala-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap) at the European Respiratory Society (Ers) Congress 2024 September 7th thru 11th
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
103073416 : nice
zezzzo : Don’t forget when I said will go to 7
Trytosaveabit OP zezzzo : Yup yup! GL and big profits to ya![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
zezzzo Trytosaveabit OP : Do you have any doubts about the stock?
Trytosaveabit OP zezzzo : Not the stock! But I do on how market makers may manipulate it if it gets a huge buy volume! JMO
zezzzo Trytosaveabit OP : Yes, it is possible. I trust your POV
Trytosaveabit OP zezzzo : Thank you for the kind words